Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
26
Number of overlapping holdings
33.8%
% of FXH's 78 holdings also in FMED
44.8%
% of FMED's 65 holdings also in FXH
Overlap by Weight
Sector Drift (FXH minus FMED)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FXH |
Weight in FMED |
Overlap | |
|---|---|---|---|---|
 |
INSULET CORP | 2.7% | 3.4% | 2.7% |
|
ALNYLAM PHARMACEUTICALS INC | 2.1% | 4.4% | 2.1% |
|
INTUITIVE SURGICAL INC | 1.9% | 3.8% | 1.9% |
|
UNITEDHEALTH GROUP INC | 1.6% | 4.7% | 1.6% |
|
EDWARDS LIFESCIENCES CORP | 1.6% | 1.5% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
FXH Overweight Relative to FMED
|
NATERA INC | 2.7% |
 |
JAZZ PHARMACEUTICALS PLC | 2.6% |
|
PREMIER INC-CLASS A | 2.5% |
 |
ROIVANT SCIENCES LTD. | 2.4% |
|
EXELIXIS INC | 2.4% |
|
UNITED THERAPEUTICS CORP | 2.4% |
|
DAVITA INC | 2.2% |
|
DOXIMITY, INC. CLASS A | 2.1% |
|
ULTRAGENYX PHARMACEUTICAL IN | 1.9% |
|
TENET HEALTHCARE CORP | 1.9% |
FXH Underweight Relative to FMED
|
BOSTON SCIENTIFIC CORP | -5.6% |
|
DANAHER CORP | -3.6% |
|
UNITEDHEALTH GROUP INC | -3.1% |
|
LEGEND BIOTECH CORPORATION SPONSORED | -3.0% |
 |
ARGENX SE ADR | -2.9% |
|
REGENERON PHARMACEUTICALS | -2.8% |
|
UCB SA | -2.3% |
|
ALNYLAM PHARMACEUTICALS INC | -2.3% |
|
MERCK & CO. INC. | -2.3% |
|
ROYALTY PHARMA PLC CLASS A | -2.1% |